Abstract 3902: A novel biologic ADI-TRAIL fusion protein benefits from structural and functional complementarity of its components arginine deiminase and TRAIL, induces cancer cell apoptosis in vitro, and inhibits tumor growth in vivo
Brin, Elena, Wu, Katherine, He, Yudou, Shia, Wei-Jong, Kuo, Mario M., Chen, Li-Chang, Dagostino, Eleanor, Hickey, Richard, Almassy, Bob, Showalter, Richard, Thomson, Jim
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article